Bronnen
Bertelsen, H. et al. (2003): “Blunting effect of D-tagatose on blood glucose when administered orally with glucose in volunteer donors of boundary glycemic levels.” Als voorbereiding op een publicatie in Japan Clinical Nutrition Journal.
Bertelsen, H. et al. (2001): “Tagatose.” Alternative Sweeteners: Third Edition, Revised and Expanded. Ed. Lyn O’Brien Nabors, 105-127.
Boesch, C. et al. (2001). “Effect of oral D-tagatose on liver volume and hepatic glycogen accumulation in healthy male volunteers.” Regulatory Toxicology and Pharmacology 33, 257-267.
Buemann, B. et al. (2000): “D-tagatose, a stereoisomer of D-fructose, increases blood uric acid concentrations.” Metabolisms. Vol. 49, No 8 (Augustust), 969-976.
Donner, T.W., Wilber J.F., Ostrowski D.: “D-tagatose, a novel hexose: Acute effects on carbohydrate tolerance in subjects with and without type 2 diabetes.” Diabetes. Obesity and Metabolism. 1999: 1, 285-291.
Joint FAO/WHO Expert Committee on Food Additives, Sixty-Third Meeting. Geneva, 8-17 June 2004. Summary and Conclusions. http://www.who.int/ipcs/publications/jecfa/en/Summary63final.pdf
U.S. Food and Drug Administration, “Health Claims: Dietary Noncariogenic Carbohydrate Sweeteners and Dental Caries” in: Code of Federal Regulations, U.S. Government Printing Office, 2003, Sec. 101.80.
